Condition: Bicuspid Aortic Valve (BAV) · Sponsor: IRCCS San Raffaele
Transcatheter aortic valve replacement (TAVR) outcomes in patients with raphe-type bicuspid aortic valve (BAV) are still suboptimal for the non negligible rate of stroke and permanent pacemaker implantation. There is still lack of consensus on the optimal sizing method for prosthesis selection in BAV patients. The objective of the present study is to evaluate the efficacy and safety of the LIRA sizing method in raphe-type BAV patients undergoing TAVR.
This description comes directly from the study's public registry record.
Prof. Matteo Montorfano, MD · 0039/02/26437331 · montorfano.matteo@hsr.it
Barbara Bellini, MD · 0039/02/26437331 · bellini.barbara@hsr.it
Always discuss trial participation with your own doctor first.
| Fondazione Poliambulanza | Brescia, Italy, Italy | Recruiting |
| Spedali Civili | Brescia, Italy, Italy | Recruiting |
| Ospedale San Donato | Milan, Italy, Italy | Recruiting |
| San Camillo Hospital | Roma, Italy, Italy | Recruiting |
| Luzerner Kantonsspital | Lucerne, Switzerland, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06657911